569 related articles for article (PubMed ID: 29569857)
1. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
[TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study.
Meisinger C; Freuer D; Bub A; Linseisen J
Lipids Health Dis; 2021 Jul; 20(1):81. PubMed ID: 34332593
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
Cervellati C; Bonaccorsi G; Trentini A; Valacchi G; Sanz JM; Squerzanti M; Spagnolo M; Massari L; Crivellari I; Greco P; Parladori R; Passaro A; Ricci G
Scand J Clin Lab Invest; 2018; 78(1-2):18-24. PubMed ID: 29168398
[TBL] [Abstract][Full Text] [Related]
4. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
[TBL] [Abstract][Full Text] [Related]
6. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
[TBL] [Abstract][Full Text] [Related]
7. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.
Erdem FH; Karatay S; Yildirim K; Kiziltunc A
Clinics (Sao Paulo); 2010 Feb; 65(2):175-9. PubMed ID: 20186301
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
10. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis.
Eder L; Thavaneswaran A; Chandran V; Cook R; Gladman DD
Ann Rheum Dis; 2015 Oct; 74(10):1830-5. PubMed ID: 24827532
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Saeed SA; Elsharkawy M; Elsaeed K; Fooda O
Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870
[TBL] [Abstract][Full Text] [Related]
12. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW
Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020
[TBL] [Abstract][Full Text] [Related]
14. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
Montaudié H; Albert-Sabonnadière C; Acquacalda E; Fontas E; Danré A; Roux C; Ortonne JP; Lacour JP; Euller-Ziegler L; Passeron T
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1186-91. PubMed ID: 23981008
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
Tang WH; Hartiala J; Fan Y; Wu Y; Stewart AF; Erdmann J; Kathiresan S; ; Roberts R; McPherson R; Allayee H; Hazen SL
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2803-12. PubMed ID: 22982463
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum paraoxonase and arylesterase activities in patients with rosacea.
Takci Z; Bilgili SG; Karadag AS; Kucukoglu ME; Selek S; Aslan M
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):367-370. PubMed ID: 24854673
[TBL] [Abstract][Full Text] [Related]
18. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.
Kenar G; Yarkan H; Zengin B; Can G; Birlik M; Önen F
Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455
[TBL] [Abstract][Full Text] [Related]
19. Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis.
Leijten E; Tao W; Pouw J; van Kempen T; Olde Nordkamp M; Balak D; Tekstra J; Muñoz-Elías E; DePrimo S; Drylewicz J; Pandit A; Boes M; Radstake T
Rheumatology (Oxford); 2021 Feb; 60(2):751-761. PubMed ID: 32793974
[TBL] [Abstract][Full Text] [Related]
20. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
